Background: Clonal haematopoiesis (CH), the age-related expansion of mutated blood stem cells, is detectable in around 10% of people in their seventies, rises steeply with age, and is associated with several diseases. Its relationship with neurodegeneration remains contentious, with conflicting evidence for both protective and detrimental effects on Alzheimer’s disease (AD). Methods: Here, we applied COMET, a mutation-agnostic, methylation-based predictor of clonal haematopoiesis burden that estimates predicted VAF (pVAF), to examine longitudinal associations between clonal burden and brain st
Clonal Haematopoiesis Tracks Alzheimer's-like Cortical Atrophy in Community-Dwelling Older Adults
calendar_today
September 12, 2026
person
Suwanlikit, Y., Crofts, S. J. C., Moodie, J. E., Marioni, R., Robertson, N. A., Tan, S. H., Vivithanaporn, P., Bastin, M. E., Wardlaw, J. M., Kirschner, K., Cox, S. R., Chandra, T.
domain
medrxiv